<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2012-11-28 05:14:00Antidepressants Organochlorides Selective serotonin reuptake inhibitors Organofluorides Monoamine oxidase inhibitors Paroxetine Serotonin–norepinephrine–dopamine reuptake inhibitor Venlafaxine Sertraline Chemistry Organic chemistry Psychiatry |
| 12.10 News Feat Ketamine MHDocID: 1gjJQ - View Document |
| Evolutionof the antidepressant consumption in France, Germany and the United KingdomDocID: 1fY13 - View Document |
| PROCEEDINGS Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaDocID: 1b326 - View Document |
| ACADIA PHARMACEUTICALS 2014 ANNUAL REPORT > ABOUT US We are a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and relateDocID: 172wi - View Document |
| Kwartaalbericht 1e kwartaalmei 2002 InhoudDocID: 15SJj - View Document |